William James

18.0k total citations · 1 hit paper
135 papers, 6.3k citations indexed

About

William James is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, William James has authored 135 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 38 papers in Virology and 35 papers in Immunology. Recurrent topics in William James's work include HIV Research and Treatment (38 papers), Immune Cell Function and Interaction (16 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). William James is often cited by papers focused on HIV Research and Treatment (38 papers), Immune Cell Function and Interaction (16 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). William James collaborates with scholars based in United Kingdom, United States and Malaysia. William James's co-authors include Sally A. Cowley, Abdessamad Tahiri‐Alaoui, Siamon Gordon, Michael D. Moore, Julian Buchrieser, Richard Wade‐Martins, Andrew Rhodes, A. Neil Barclay, Jane Vowles and Heyne Lee and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

William James

132 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 Variants, Vaccines, and Host Immunity

2022 197 citations William James, Siamon Gordon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William James United Kingdom	44	3.0k	1.3k	1.3k	848	782	135	6.3k
Dominique Dormont France	51	4.4k 1.5×	1.6k 1.3×	1.3k 1.0×	2.1k 2.5×	258 0.3×	282	8.5k
Alan Shaw United States	50	3.4k 1.1×	2.7k 2.2×	896 0.7×	398 0.5×	495 0.6×	109	9.2k
Pierre Charneau France	47	3.8k 1.3×	1.6k 1.3×	2.1k 1.7×	2.6k 3.1×	512 0.7×	111	8.3k
Ehud Lavi United States	46	1.1k 0.4×	1.7k 1.4×	1.6k 1.3×	1.1k 1.3×	208 0.3×	154	6.8k
Leo C. James United Kingdom	48	4.5k 1.5×	3.0k 2.4×	2.3k 1.8×	2.2k 2.6×	385 0.5×	112	9.1k
Hans‐Walter Pfister Germany	52	1.1k 0.4×	1.7k 1.4×	1.3k 1.1×	226 0.3×	853 1.1×	161	7.0k
Susan V. Westmoreland United States	34	1.0k 0.3×	1.1k 0.9×	825 0.7×	1.7k 2.0×	313 0.4×	104	4.5k
Francisco González‐Scarano United States	54	2.0k 0.7×	2.1k 1.7×	2.9k 2.3×	3.8k 4.5×	1.2k 1.6×	123	9.4k
Jean‐Philippe Julien Canada	46	3.4k 1.2×	2.5k 2.0×	1.6k 1.3×	4.1k 4.9×	525 0.7×	158	8.1k
Robyn S. Klein United States	55	2.0k 0.7×	3.4k 2.7×	1.7k 1.3×	363 0.4×	1.5k 1.9×	126	9.6k

Countries citing papers authored by William James

Since Specialization

Citations

This map shows the geographic impact of William James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William James more than expected).

Fields of papers citing papers by William James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William James. The network helps show where William James may publish in the future.

Co-authorship network of co-authors of William James

This figure shows the co-authorship network connecting the top 25 collaborators of William James. A scholar is included among the top collaborators of William James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William James. William James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Tiong Kit, Alexander A. Cohen, Jennifer R. Keeffe, et al.. (2024). Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses. Nature Nanotechnology. 19(8). 1216–1223. 25 indexed citations

Gelinas, Amy D., Tiong Kit Tan, Sai Liu, et al.. (2023). Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents. Molecular Therapy — Nucleic Acids. 31. 370–382. 12 indexed citations

Komarasamy, Thamil Vaani, et al.. (2022). Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses. PLoS neglected tropical diseases. 16(4). e0010291–e0010291. 14 indexed citations

Komarasamy, Thamil Vaani, et al.. (2022). Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy. Frontiers in Microbiology. 13. 743147–743147. 18 indexed citations

Cahill, Thomas J., Xin Sun, Christophe Ravaud, et al.. (2021). Tissue-resident macrophages regulate lymphatic vessel growth and patterning in the developing heart. Development. 148(3). 70 indexed citations

Lee, Young Seok, Peter A. C. Wing, Marko Noerenberg, et al.. (2021). Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences. eLife. 11. 31 indexed citations

Mendonça, Luiza, Andrew Howe, James B. Gilchrist, et al.. (2021). Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress. Nature Communications. 12(1). 4629–4629. 122 indexed citations

Ebrahimi, Kourosh Honarmand, Duncan Howie, Jack S. Rowbotham, et al.. (2020). Viperin, through its radical‐SAM activity, depletes cellular nucleotide pools and interferes with mitochondrial metabolism to inhibit viral replication. FEBS Letters. 594(10). 1624–1630. 27 indexed citations

Ebrahimi, Kourosh Honarmand, Jack S. Rowbotham, James McCullagh, & William James. (2020). Cover Feature: Mechanism of Diol Dehydration by a Promiscuous Radical‐SAM Enzyme Homologue of the Antiviral Enzyme Viperin (RSAD2) (ChemBioChem 11/2020). ChemBioChem. 21(11). 1545–1545.

10.

Ebrahimi, Kourosh Honarmand, Javier Gilbert‐Jaramillo, William James, & James McCullagh. (2020). Interferon‐stimulated gene products as regulators of central carbon metabolism. FEBS Journal. 288(12). 3715–3726. 13 indexed citations

11.

Ebrahimi, Kourosh Honarmand, Jack S. Rowbotham, James McCullagh, & William James. (2020). Mechanism of Diol Dehydration by a Promiscuous Radical‐SAM Enzyme Homologue of the Antiviral Enzyme Viperin (RSAD2). ChemBioChem. 21(11). 1605–1612. 20 indexed citations

12.

Ebrahimi, Kourosh Honarmand, Jane Vowles, Cathy Browne, James McCullagh, & William James. (2020). ddhCTP produced by the radical‐SAM activity of RSAD2 (viperin) inhibits the NAD⁺‐dependent activity of enzymes to modulate metabolism. FEBS Letters. 594(10). 1631–1644. 34 indexed citations

13.

Haenseler, Walther, Heyne Lee, Jane Vowles, et al.. (2017). Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages. Scientific Reports. 7(1). 9003–9003. 93 indexed citations

14.

Wilgenburg, Bonnie van, et al.. (2012). Several Commercially Available Anti-CCR5 Monoclonal Antibodies Lack Specificity and Should Be Used with Caution. Hybridoma. 31(1). 7–19. 9 indexed citations

15.

Rhie, Alexandre, et al.. (2004). Structural Determinants of Conformationally Selective, Prion-binding Aptamers. Journal of Biological Chemistry. 279(13). 13102–13109. 83 indexed citations

16.

Griffin, Philip, et al.. (1999). Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes. Virus Research. 60(2). 159–169. 39 indexed citations

17.

Simon, James H. M. & William James. (1994). Heterokaryons Formed between a Rat Myeloma and a Mouse Fibroblast Are Permissive for Entry of HIV Type 1. AIDS Research and Human Retroviruses. 10(12). 1609–1611. 4 indexed citations

18.

Press, Michael F., Malcolm C. Pike, Gene Hung, et al.. (1994). Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.. PubMed. 54(21). 5675–82. 176 indexed citations

19.

Lucas, F Anthony San, et al.. (1993). A novel model of a metastatic human breast tumour xenograft line. British Journal of Cancer. 68(2). 274–276. 36 indexed citations

20.

Doyle, Anthony, Matthew Collin, Georges Herbein, et al.. (1993). Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.. The Journal of Experimental Medicine. 178(2). 743–747. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact